A Cambridge institute dedicated to improving cardiovascular and lung health has received a £16 million gift from Canadian entrepreneur and philanthropist Dr Victor Dahdaleh.
A drug used to reduce the risk of blood clots does not help patients recovering from moderate and severe COVID-19, despite this approach being offered to patients, a UK-wide trial, led by Addenbrooke’s Hospital and the University of Cambridge has found.
A major new institute opens today, bringing together the largest concentration of scientists and clinicians in heart and lung medicine in Europe.
A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19.
An intensive care specialist at Addenbrooke’s Hospital, Charlotte Summers has spent the last few months dealing with the biggest challenge of her career. And after long, exhausting days, the weekly Clap for Carers caught her by surprise.
© 2024 University of Cambridge